These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170 [TBL] [Abstract][Full Text] [Related]
4. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729 [TBL] [Abstract][Full Text] [Related]
5. Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. Steel HC; Anderson R Br J Pharmacol; 2002 May; 136(1):81-9. PubMed ID: 11976271 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin. Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203 [TBL] [Abstract][Full Text] [Related]
7. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600 [TBL] [Abstract][Full Text] [Related]
8. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. Barbuti A; Ishii S; Shimizu T; Robinson RB; Feinmark SJ Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2024-30. PubMed ID: 12003807 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. Youker K; Smith CW; Anderson DC; Miller D; Michael LH; Rossen RD; Entman ML J Clin Invest; 1992 Feb; 89(2):602-9. PubMed ID: 1346618 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists. Nguyên P; Petitfrère E; Potron G Thromb Res; 1995 Apr; 78(1):33-42. PubMed ID: 7778064 [TBL] [Abstract][Full Text] [Related]
11. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation. Zhou W; Javors MA; Olson MS Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973 [TBL] [Abstract][Full Text] [Related]
12. CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages. Stewart AG Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):813-20. PubMed ID: 2558827 [TBL] [Abstract][Full Text] [Related]
19. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. Kuijpers TW; van den Berg JM; Tool AT; Roos D Clin Exp Immunol; 2001 Mar; 123(3):412-20. PubMed ID: 11298128 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate. Bruijnzeel PL; Warringa RA; Kok PT Br J Pharmacol; 1989 Aug; 97(4):1251-7. PubMed ID: 2551444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]